V-Square Quantitative Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

V-Square Quantitative Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-394	Closed	-$22.5K	–	728
2026 Q2	$22.5K	Sell	394 -403	-51%	-$22.1K	﹤0.01%	703
2026 Q1	$45K	Buy	797 +44	+6%	+$2.56K	﹤0.01%	601
2025 Q4	$44.8K	Buy	+753	New	+$41K	﹤0.01%	586
2025 Q3	–	Sell	-450	Closed	-$24.7K	–	208
2025 Q2	$24.7K	Buy	+450	New	+$26.5K	﹤0.01%	586

Other funds holding BMRN

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Covea Finance Paris, France $3.07B AUM 27.46% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Secure Asset Management Troy, Michigan $753M AUM 20.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return

V-Square Quantitative Management's BMRN Position: Q3 2026 in Review

V-Square Quantitative Management sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2026, closing a stake of 394 shares — an estimated $22.5K sold.

V-Square Quantitative Management first reported a position in BMRN in Q2 2025 and held it in 4 quarters. The position peaked at $45K in Q1 2026. 71 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

V-Square Quantitative Management reported no remaining BioMarin Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
V-Square Quantitative Management sold 394 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $22.5K.
V-Square Quantitative Management first reported a position in BioMarin Pharmaceuticals in Q2 2025 and held it in 4 quarters.
V-Square Quantitative Management's BioMarin Pharmaceuticals position peaked at $45K in Q1 2026.
71 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.